NEOK Bio: Valuation, Funding & Investors
NEOK Bio, Inc. is a biotechnology company focused on the development of novel antibody drug conjugates (ADCs) that are designed to improve outcomes for cancer patients. NEOK is rapidly advancing bispecific ADCs which represent a cutting-edge advancement, leveraging bispecific antibodies that target two complimentary antigens, potentially improving safety while enhancing the efficacy of ADCs in a wider range of tumors.
Leadership & Board
- Current Number of Employees
- 6
- Current LinkedIn Followers
- 983
Latest Estimated Valuation
- Total Amount Raised
- $75M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $75M
- Latest Funding Round
- Series A
Employee Trend
NEOK Bio had 6 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
NEOK Bio had 983 followers as of October 26, 2026. The number of followers increased by 2 (0.20%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 04, 2025 | Series A | $75.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| ABL Bio, Inc. | Series A |
Similar Companies
A snapshot of private companies similar to NEOK Bio, helping you discover and navigate related company profiles.
Related News and Analysis
